USE OF MYORELAXANTS IN THE TREATMENT OF RADICULOPATHY

Download full text PDF
Issue: 
4
Year: 
2015

I. Eremeeva, I. Ryazantseva, R. Khamitova Hospital №36, Angarsk

Whether baclofen may be used in the occurrence of muscle tone syndrome in patients with dorsopathy has been studied. Combination treatment with myorelaxants has been shown to be effective in patients with spondylogenic radicular ischemia due to degenerative and dystrophic changes in the spine.
Keywords: 
radiculopathy
myofascial syndrome
lumbar ischialgia
Baclosan

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Federal'naja sluzhba gosudarstvennoj statistiki (Rosstat). Demograficheskij ezhegodnik Rossii – 2013 god. Elektronnyj resurs. URL:http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/publications/catalog/doc_1137674209312
  2. Stamler J., Wentworth D., Neaton D. Prevalence and prognostic significance of hypercholesterolemia in men with hypertension: Prospective data on the primary screenees of the Multiple Risk Factor Intervention Trial // Am J Med. – 1986; 80: 33–9.
  3. Karpov Ju.A. Lechenie bol'nyh serdechno-sosudistymi zabolevanijami: rol' blokady renin-angiotenzinovoj sistemy s pomosch'ju sartanov // Rus. med. zhurn. – 2009; 23: 1548–54.
  4. Medvedev I.N., Kumova T.A., Gamolina O.V. Rol' renin-angiotenzin- al'dosteronovoj sistemy v razvitii arterial'noj gipertonii // Ros. kardi-ol. zhurn. – 2009; 4: 82–4.
  5. Ostroumova O.D., Maksimov M.L. Mesto ingibitorov angiotenzin prevraschajuschego fermenta v lechenii arterial'noj gipertonii u razlichnyh grupp patsientov // Kardiovask. ter. i profilakt. – 2010; 9 (7): 90–6.
  6. Ferrario C., Richmond R., Smith R. et al. Renin-angiotensin system as a therapeutic target in managing atherosclerosis // Am. J. Ther. – 2004; 11 (1): 44–53.
  7. Morgado M., Rolo S., Macedo A. et al. Association of statin therapy with blood pressure control in hypertensive hypercholesterolemic outpatients in clinical practice // J. Cardiovasc. Dis. Res. – 2011; 2 (1): 44–9
  8. Borghi C., Prandin G., Costa V. et al. Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia // J. Cardiovasc. Pharmacol. – 2000; 35: 549–55.
  9. Borghi C., Dormi A., Veronesi M. et al. Association between different lipid lowering treatment strategies and blood pressure control in the Brisighella Heart Study // Am. Heart J. – 2004; 148: 285–92.
  10. Winocour P. Drug therapy for prevention of cardiovascular disease – should surrogate measures be abandoned? // Clin. Med. – 2005; 5: 282–7.
  11. Dagenais G., Pogue J., Fox K. et al. Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials // Lancet. – 2006; 12, 368 (9535): 581–8.
  12. Chazova I.E., Kuharchuk V.V., Ratova L.G. i dr. Vozmozhnosti gipolipidemicheskoj terapii bol'nyh arterial'noj gipertoniej (po rezul'tatam pro-grammy ROZA – ROZuvastatin u patsientov s Arterial'noj gipertoniej) // Sistemnye gipertenzii. – 2006; 2: 23–6.